131 related articles for article (PubMed ID: 21457513)
41. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
[TBL] [Abstract][Full Text] [Related]
42. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
[TBL] [Abstract][Full Text] [Related]
43. Selected angiogenic factors in plasma of patients with lower limb symptomatic peripheral arterial disease: preliminary report.
Wieczór R; Gadomska G; Góralczyk B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
Int Angiol; 2015 Dec; 34(6):545-51. PubMed ID: 25394959
[TBL] [Abstract][Full Text] [Related]
44. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study.
Seet RC; Chow AW; Quek AM; Chan YH; Lim EC
Int J Infect Dis; 2009 Sep; 13(5):e248-53. PubMed ID: 19261502
[TBL] [Abstract][Full Text] [Related]
45. The relationship between the VEGF/sVEGFR-1 ratio and threatened abortion.
Keskin U; Ulubay M; Dede M; Ozgurtas T; Koçyiğit YK; Aydin FN; Ergün A
Arch Gynecol Obstet; 2015 Mar; 291(3):557-61. PubMed ID: 25200689
[TBL] [Abstract][Full Text] [Related]
46. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
[TBL] [Abstract][Full Text] [Related]
47. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis.
Robbie LA; Dummer S; Booth NA; Adey GD; Bennett B
Br J Haematol; 2000 May; 109(2):342-8. PubMed ID: 10848822
[TBL] [Abstract][Full Text] [Related]
48. Is serum-soluble vascular endothelial growth factor receptor-1 of importance in unexplained infertility?
Wathén KA; Unkila-Kallio L; Isaksson R; Tiitinen A; Stenman UH; Vuorela P
Acta Obstet Gynecol Scand; 2008; 87(7):738-44. PubMed ID: 18607827
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of endothelial biomarkers as predictors of organ failures in septic shock patients.
Palud A; Parmentier-Decrucq E; Pastre J; De Freitas Caires N; Lassalle P; Mathieu D
Cytokine; 2015 Jun; 73(2):213-8. PubMed ID: 25794660
[TBL] [Abstract][Full Text] [Related]
50. The DISPARITY-II study: delays to antibiotic administration in women with severe sepsis or septic shock.
Madsen TE; Napoli AM
Acad Emerg Med; 2014 Dec; 21(12):1499-502. PubMed ID: 25424151
[TBL] [Abstract][Full Text] [Related]
51. Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis.
Tsao PN; Chan FT; Wei SC; Hsieh WS; Chou HC; Su YN; Chen CY; Hsu WM; Hsieh FJ; Hsu SM
Crit Care Med; 2007 Aug; 35(8):1955-60. PubMed ID: 17568329
[TBL] [Abstract][Full Text] [Related]
52. Increased serum level of soluble vascular endothelial growth factor receptor-1 is associated with poor coronary collateralization in patients with stable coronary artery disease.
Sun Z; Shen Y; Lu L; Zhang RY; Pu LJ; Zhang Q; Yang ZK; Hu J; Chen QJ; Shen WF
Circ J; 2014; 78(5):1191-6. PubMed ID: 24583918
[TBL] [Abstract][Full Text] [Related]
53. Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients.
von Dossow V; Rotard K; Redlich U; Hein OV; Spies CD
Crit Care; 2005; 9(6):R662-9. PubMed ID: 16280065
[TBL] [Abstract][Full Text] [Related]
54. The role of VEGF and its soluble receptor VEGFR-1 in preterm newborns of preeclamptic mothers with RDS.
Kalay S; Cakcak B; Oztekin O; Tezel G; Tosun O; Akcakus M; Oygur N
J Matern Fetal Neonatal Med; 2013 Jul; 26(10):978-83. PubMed ID: 23339636
[TBL] [Abstract][Full Text] [Related]
55. Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism.
Emanuele E; Orsi P; Barale F; di Nemi SU; Bertona M; Politi P
Clin Biochem; 2010 Feb; 43(3):317-9. PubMed ID: 19850021
[TBL] [Abstract][Full Text] [Related]
56. Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.
Hsu LH; Hsu PC; Liao TL; Feng AC; Chu NM; Kao SH
BMC Cancer; 2016 Jul; 16():463. PubMed ID: 27411914
[TBL] [Abstract][Full Text] [Related]
57. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
[TBL] [Abstract][Full Text] [Related]
58. Elevated nucleosome levels in systemic inflammation and sepsis.
Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
[TBL] [Abstract][Full Text] [Related]
59. Osteopontin induces soluble urokinase-type plasminogen activator receptor production and release.
Vaschetto R; Navalesi P; Clemente N; Boggio E; Valsecchi S; Olivieri C; Soluri MF; Kroumova V; Fonio P; Dinatale C; Borrè S; Fortina G; Umberto D; Della Corte F; Chiocchetti A
Minerva Anestesiol; 2015 Feb; 81(2):157-65. PubMed ID: 24994498
[TBL] [Abstract][Full Text] [Related]
60. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction.
Matsuda N; Hattori Y
J Smooth Muscle Res; 2007 Aug; 43(4):117-37. PubMed ID: 17928746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
